ArticleBJUI compass2026
Robotic retroperitoneal surgery in a uro-oncology specialised centre: Translating RPLND expertise from testicular cancer to non-genitourinary retroperitoneal tumour resection.
Article in BJUI compass, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The aim of this study is to evaluate the feasibility and perioperative outcomes of robotic-assisted resection of selected non-genitourinary retroperitoneal tumours (RA-RTR) performed by urologists with established experience in robotic retroperitoneal lymph node dissection (RA-RPLND) within a specialised centre. Methods: A retrospective analysis was conducted of all patients undergoing RA-RPLND for testicular cancer and RA-RTR for non-genitourinary tumours between January 2022 and May 2025. Procedures for renal, adrenal and upper tract urothelial malignancies were excluded. All operations were performed using a four-port da Vinci Xi® platform. Results: Forty-five patients were included: 27 RA-RPLND and 18 RA-RTR. RA-RTR patients were older (median 50 vs. 36 years, Conclusion: Comparable perioperative outcomes between RA-RTR and RA-RPLND indicate that these surgeries can be performed in specialised centres by urologists experienced in complex retroperitoneal surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.